nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—type 2 diabetes mellitus—polycystic ovary syndrome	0.624	1	CtDrD
Ramipril—ACE—polycystic ovary syndrome	0.31	1	CbGaD
Ramipril—ACE—tunica intima—polycystic ovary syndrome	0.00719	0.274	CbGeAlD
Ramipril—ACE—urine—polycystic ovary syndrome	0.00354	0.135	CbGeAlD
Ramipril—ACE—Metabolism of Angiotensinogen to Angiotensins—CPB2—polycystic ovary syndrome	0.00228	0.194	CbGpPWpGaD
Ramipril—SLC15A1—endometrium—polycystic ovary syndrome	0.00117	0.0444	CbGeAlD
Ramipril—ACE—embryo—polycystic ovary syndrome	0.00114	0.0435	CbGeAlD
Ramipril—SLC15A1—vagina—polycystic ovary syndrome	0.000874	0.0333	CbGeAlD
Ramipril—ACE—endometrium—polycystic ovary syndrome	0.000836	0.0319	CbGeAlD
Ramipril—SLC15A1—endocrine gland—polycystic ovary syndrome	0.000818	0.0312	CbGeAlD
Ramipril—ACE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.000791	0.0673	CbGpPWpGaD
Ramipril—ACE—pituitary gland—polycystic ovary syndrome	0.000757	0.0288	CbGeAlD
Ramipril—Neuropathy—Metformin—polycystic ovary syndrome	0.000757	0.032	CcSEcCtD
Ramipril—ACE—adipose tissue—polycystic ovary syndrome	0.000754	0.0287	CbGeAlD
Ramipril—SLC15A2—endometrium—polycystic ovary syndrome	0.000729	0.0278	CbGeAlD
Ramipril—Lightheadedness—Metformin—polycystic ovary syndrome	0.000721	0.0305	CcSEcCtD
Ramipril—ACE—adrenal gland—polycystic ovary syndrome	0.000676	0.0258	CbGeAlD
Ramipril—SLC15A2—pituitary gland—polycystic ovary syndrome	0.00066	0.0251	CbGeAlD
Ramipril—Nasal congestion—Metformin—polycystic ovary syndrome	0.000642	0.0271	CcSEcCtD
Ramipril—ACE—female gonad—polycystic ovary syndrome	0.00063	0.024	CbGeAlD
Ramipril—BCHE—endometrium—polycystic ovary syndrome	0.000618	0.0235	CbGeAlD
Ramipril—Renal impairment—Metformin—polycystic ovary syndrome	0.000615	0.026	CcSEcCtD
Ramipril—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000599	0.0253	CcSEcCtD
Ramipril—ACE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.000599	0.051	CbGpPWpGaD
Ramipril—SLC15A2—adrenal gland—polycystic ovary syndrome	0.00059	0.0225	CbGeAlD
Ramipril—ACE—endocrine gland—polycystic ovary syndrome	0.000586	0.0223	CbGeAlD
Ramipril—BCHE—uterus—polycystic ovary syndrome	0.000569	0.0217	CbGeAlD
Ramipril—BCHE—pituitary gland—polycystic ovary syndrome	0.000559	0.0213	CbGeAlD
Ramipril—BCHE—adipose tissue—polycystic ovary syndrome	0.000557	0.0212	CbGeAlD
Ramipril—SLC15A2—female gonad—polycystic ovary syndrome	0.00055	0.0209	CbGeAlD
Ramipril—SLC15A2—vagina—polycystic ovary syndrome	0.000546	0.0208	CbGeAlD
Ramipril—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00054	0.0228	CcSEcCtD
Ramipril—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000534	0.0226	CcSEcCtD
Ramipril—Breast disorder—Metformin—polycystic ovary syndrome	0.000529	0.0223	CcSEcCtD
Ramipril—Cramp muscle—Metformin—polycystic ovary syndrome	0.000527	0.0222	CcSEcCtD
Ramipril—SLC15A2—endocrine gland—polycystic ovary syndrome	0.000511	0.0195	CbGeAlD
Ramipril—Influenza—Metformin—polycystic ovary syndrome	0.000506	0.0214	CcSEcCtD
Ramipril—BCHE—adrenal gland—polycystic ovary syndrome	0.000499	0.019	CbGeAlD
Ramipril—Pancreatitis—Metformin—polycystic ovary syndrome	0.000496	0.0209	CcSEcCtD
Ramipril—Angina pectoris—Metformin—polycystic ovary syndrome	0.000493	0.0208	CcSEcCtD
Ramipril—Sweating increased—Metformin—polycystic ovary syndrome	0.000493	0.0208	CcSEcCtD
Ramipril—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000485	0.0205	CcSEcCtD
Ramipril—Neutropenia—Metformin—polycystic ovary syndrome	0.000473	0.02	CcSEcCtD
Ramipril—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00047	0.0198	CcSEcCtD
Ramipril—BCHE—vagina—polycystic ovary syndrome	0.000463	0.0176	CbGeAlD
Ramipril—ACE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.000454	0.0387	CbGpPWpGaD
Ramipril—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000442	0.0187	CcSEcCtD
Ramipril—BCHE—endocrine gland—polycystic ovary syndrome	0.000433	0.0165	CbGeAlD
Ramipril—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000426	0.018	CcSEcCtD
Ramipril—Hepatitis—Metformin—polycystic ovary syndrome	0.000405	0.0171	CcSEcCtD
Ramipril—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000399	0.0168	CcSEcCtD
Ramipril—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000398	0.0168	CcSEcCtD
Ramipril—Fosinopril—ACE—polycystic ovary syndrome	0.000385	0.107	CrCbGaD
Ramipril—Flushing—Metformin—polycystic ovary syndrome	0.000376	0.0159	CcSEcCtD
Ramipril—Immune system disorder—Metformin—polycystic ovary syndrome	0.000366	0.0154	CcSEcCtD
Ramipril—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000365	0.0154	CcSEcCtD
Ramipril—Malnutrition—Metformin—polycystic ovary syndrome	0.000352	0.0149	CcSEcCtD
Ramipril—Erythema—Metformin—polycystic ovary syndrome	0.000352	0.0149	CcSEcCtD
Ramipril—Dysgeusia—Metformin—polycystic ovary syndrome	0.000345	0.0146	CcSEcCtD
Ramipril—Muscle spasms—Metformin—polycystic ovary syndrome	0.000339	0.0143	CcSEcCtD
Ramipril—ACE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000336	0.0286	CbGpPWpGaD
Ramipril—Tremor—Metformin—polycystic ovary syndrome	0.00033	0.0139	CcSEcCtD
Ramipril—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000327	0.0138	CcSEcCtD
Ramipril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—polycystic ovary syndrome	0.000323	0.0275	CbGpPWpGaD
Ramipril—Malaise—Metformin—polycystic ovary syndrome	0.000318	0.0134	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.000317	0.027	CbGpPWpGaD
Ramipril—Syncope—Metformin—polycystic ovary syndrome	0.000316	0.0133	CcSEcCtD
Ramipril—Perindopril—ACE—polycystic ovary syndrome	0.000314	0.0874	CrCbGaD
Ramipril—Palpitations—Metformin—polycystic ovary syndrome	0.000311	0.0131	CcSEcCtD
Ramipril—Spirapril—ACE—polycystic ovary syndrome	0.000311	0.0865	CrCbGaD
Ramipril—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00031	0.0131	CcSEcCtD
Ramipril—Chest pain—Metformin—polycystic ovary syndrome	0.0003	0.0127	CcSEcCtD
Ramipril—Myalgia—Metformin—polycystic ovary syndrome	0.0003	0.0127	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000298	0.0126	CcSEcCtD
Ramipril—Moexipril—ACE—polycystic ovary syndrome	0.000298	0.0829	CrCbGaD
Ramipril—Mitiglinide—PPARG—polycystic ovary syndrome	0.000297	0.0826	CrCbGaD
Ramipril—Discomfort—Metformin—polycystic ovary syndrome	0.000296	0.0125	CcSEcCtD
Ramipril—Benazepril—MTHFR—polycystic ovary syndrome	0.000295	0.0822	CrCbGaD
Ramipril—Oedema—Metformin—polycystic ovary syndrome	0.000288	0.0121	CcSEcCtD
Ramipril—Shock—Metformin—polycystic ovary syndrome	0.000283	0.0119	CcSEcCtD
Ramipril—BCHE—Glycerophospholipid biosynthesis—LPCAT2—polycystic ovary syndrome	0.000282	0.024	CbGpPWpGaD
Ramipril—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000282	0.0119	CcSEcCtD
Ramipril—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000282	0.0119	CcSEcCtD
Ramipril—Skin disorder—Metformin—polycystic ovary syndrome	0.000279	0.0118	CcSEcCtD
Ramipril—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000278	0.0117	CcSEcCtD
Ramipril—Quinapril—ACE—polycystic ovary syndrome	0.000277	0.0771	CrCbGaD
Ramipril—Cilazapril—ACE—polycystic ovary syndrome	0.000277	0.0771	CrCbGaD
Ramipril—Lisinopril—ACE—polycystic ovary syndrome	0.000277	0.0771	CrCbGaD
Ramipril—Anorexia—Metformin—polycystic ovary syndrome	0.000274	0.0116	CcSEcCtD
Ramipril—Hypotension—Metformin—polycystic ovary syndrome	0.000269	0.0113	CcSEcCtD
Ramipril—Trandolapril—ACE—polycystic ovary syndrome	0.000268	0.0746	CrCbGaD
Ramipril—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000262	0.0111	CcSEcCtD
Ramipril—Paraesthesia—Metformin—polycystic ovary syndrome	0.000258	0.0109	CcSEcCtD
Ramipril—Dyspnoea—Metformin—polycystic ovary syndrome	0.000256	0.0108	CcSEcCtD
Ramipril—Somnolence—Metformin—polycystic ovary syndrome	0.000256	0.0108	CcSEcCtD
Ramipril—Dyspepsia—Metformin—polycystic ovary syndrome	0.000253	0.0107	CcSEcCtD
Ramipril—Decreased appetite—Metformin—polycystic ovary syndrome	0.00025	0.0106	CcSEcCtD
Ramipril—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000248	0.0105	CcSEcCtD
Ramipril—Fatigue—Metformin—polycystic ovary syndrome	0.000248	0.0105	CcSEcCtD
Ramipril—Constipation—Metformin—polycystic ovary syndrome	0.000246	0.0104	CcSEcCtD
Ramipril—Benazepril—ACE—polycystic ovary syndrome	0.000241	0.067	CrCbGaD
Ramipril—BCHE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00024	0.0205	CbGpPWpGaD
Ramipril—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000237	0.01	CcSEcCtD
Ramipril—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000235	0.00993	CcSEcCtD
Ramipril—Urticaria—Metformin—polycystic ovary syndrome	0.000228	0.00965	CcSEcCtD
Ramipril—Abdominal pain—Metformin—polycystic ovary syndrome	0.000227	0.0096	CcSEcCtD
Ramipril—ACE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000222	0.0189	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000206	0.0176	CbGpPWpGaD
Ramipril—Asthenia—Metformin—polycystic ovary syndrome	0.000206	0.00871	CcSEcCtD
Ramipril—Pruritus—Metformin—polycystic ovary syndrome	0.000203	0.00859	CcSEcCtD
Ramipril—Enalapril—ACE—polycystic ovary syndrome	0.000203	0.0566	CrCbGaD
Ramipril—BCHE—Phospholipid metabolism—LPCAT2—polycystic ovary syndrome	0.000197	0.0168	CbGpPWpGaD
Ramipril—Diarrhoea—Metformin—polycystic ovary syndrome	0.000197	0.00831	CcSEcCtD
Ramipril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—polycystic ovary syndrome	0.000194	0.0165	CbGpPWpGaD
Ramipril—Dizziness—Metformin—polycystic ovary syndrome	0.00019	0.00803	CcSEcCtD
Ramipril—BCHE—Glycerophospholipid biosynthesis—PNPLA2—polycystic ovary syndrome	0.000187	0.0159	CbGpPWpGaD
Ramipril—Vomiting—Metformin—polycystic ovary syndrome	0.000183	0.00772	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.000182	0.0155	CbGpPWpGaD
Ramipril—Rash—Metformin—polycystic ovary syndrome	0.000181	0.00766	CcSEcCtD
Ramipril—Dermatitis—Metformin—polycystic ovary syndrome	0.000181	0.00765	CcSEcCtD
Ramipril—Headache—Metformin—polycystic ovary syndrome	0.00018	0.00761	CcSEcCtD
Ramipril—Nausea—Metformin—polycystic ovary syndrome	0.000171	0.00721	CcSEcCtD
Ramipril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—polycystic ovary syndrome	0.000166	0.0141	CbGpPWpGaD
Ramipril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—polycystic ovary syndrome	0.00016	0.0136	CbGpPWpGaD
Ramipril—Nateglinide—PPARG—polycystic ovary syndrome	0.000151	0.0421	CrCbGaD
Ramipril—ACE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000149	0.0127	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000137	0.0116	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000135	0.0115	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000133	0.0114	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PNPLA2—polycystic ovary syndrome	0.00013	0.0111	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000115	0.00979	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.000115	0.00976	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.000114	0.0097	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.000113	0.00963	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.000113	0.00963	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00011	0.00938	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000107	0.00909	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	8.9e-05	0.00758	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	8.62e-05	0.00734	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—INHBB—polycystic ovary syndrome	8.57e-05	0.0073	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	8.28e-05	0.00705	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	8.2e-05	0.00698	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	7.69e-05	0.00655	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	7.61e-05	0.00648	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	7.41e-05	0.00631	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	6.88e-05	0.00586	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—LHB—polycystic ovary syndrome	6.34e-05	0.0054	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	6.34e-05	0.0054	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	5.99e-05	0.0051	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	5.67e-05	0.00483	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	5.48e-05	0.00466	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	5.35e-05	0.00456	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	5.18e-05	0.00441	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	5.01e-05	0.00427	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	5.01e-05	0.00427	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	4.95e-05	0.00422	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	4.8e-05	0.00409	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—LMNA—polycystic ovary syndrome	4.7e-05	0.004	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	4.6e-05	0.00392	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	4.57e-05	0.00389	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	4.54e-05	0.00387	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	4.54e-05	0.00387	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	4.42e-05	0.00377	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	4.38e-05	0.00373	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	4.2e-05	0.00358	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—GHRL—polycystic ovary syndrome	4.19e-05	0.00356	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	3.98e-05	0.00339	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	3.9e-05	0.00332	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	3.8e-05	0.00323	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	3.8e-05	0.00323	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	3.44e-05	0.00293	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	3.36e-05	0.00286	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	3.23e-05	0.00275	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.09e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	3.09e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	3.09e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.95e-05	0.00251	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.88e-05	0.00245	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.88e-05	0.00245	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.87e-05	0.00244	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	2.82e-05	0.0024	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SUOX—polycystic ovary syndrome	2.82e-05	0.0024	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.79e-05	0.00237	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.67e-05	0.00227	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.63e-05	0.00224	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	2.63e-05	0.00224	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.57e-05	0.00218	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	2.55e-05	0.00217	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—LEP—polycystic ovary syndrome	2.52e-05	0.00214	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.44e-05	0.00208	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.4e-05	0.00204	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	2.28e-05	0.00194	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.27e-05	0.00193	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	2.23e-05	0.0019	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	2.23e-05	0.0019	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.21e-05	0.00188	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.16e-05	0.00184	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—INS—polycystic ovary syndrome	2.15e-05	0.00183	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.15e-05	0.00183	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.11e-05	0.0018	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.08e-05	0.00177	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.05e-05	0.00174	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	1.89e-05	0.0016	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	1.87e-05	0.00159	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	1.77e-05	0.00151	CbGpPWpGaD
Ramipril—BCHE—Metabolism—STAR—polycystic ovary syndrome	1.69e-05	0.00144	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	1.68e-05	0.00143	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.67e-05	0.00142	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	1.63e-05	0.00139	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	1.56e-05	0.00133	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HMMR—polycystic ovary syndrome	1.51e-05	0.00128	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	1.44e-05	0.00122	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.42e-05	0.00121	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.35e-05	0.00115	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LHB—polycystic ovary syndrome	1.31e-05	0.00112	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	1.28e-05	0.00109	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	1.24e-05	0.00106	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	1.14e-05	0.000973	CbGpPWpGaD
Ramipril—BCHE—Metabolism—RRM2—polycystic ovary syndrome	1.11e-05	0.000942	CbGpPWpGaD
Ramipril—BCHE—Metabolism—YAP1—polycystic ovary syndrome	1.07e-05	0.000908	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	1.02e-05	0.000873	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.02e-05	0.000867	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	1.01e-05	0.000862	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	1.01e-05	0.000861	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1e-05	0.000856	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	9.56e-06	0.000814	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	9.41e-06	0.000801	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	8.68e-06	0.000739	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	8.64e-06	0.000735	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	8.35e-06	0.000711	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TH—polycystic ovary syndrome	8.14e-06	0.000693	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	7.92e-06	0.000674	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	7.45e-06	0.000634	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GNAS—polycystic ovary syndrome	6.65e-06	0.000566	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	6.33e-06	0.000539	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	6e-06	0.000511	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	5.6e-06	0.000476	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPARG—polycystic ovary syndrome	4.54e-06	0.000386	CbGpPWpGaD
Ramipril—BCHE—Metabolism—POMC—polycystic ovary syndrome	4.48e-06	0.000381	CbGpPWpGaD
Ramipril—BCHE—Metabolism—INS—polycystic ovary syndrome	4.45e-06	0.000379	CbGpPWpGaD
